U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
AZINTUXIZUMAB
INN  
INN  
Official Name English
azintuxizumab [INN]
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD319 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL PR-1471272 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1471272 LIGHT CHAIN, DIMER
Systematic Name English
Code System Code Type Description
CAS
1826819-57-1
Created by admin on Tue Apr 01 20:38:39 GMT 2025 , Edited by admin on Tue Apr 01 20:38:39 GMT 2025
PRIMARY
FDA UNII
8UAH8N2SAS
Created by admin on Tue Apr 01 20:38:39 GMT 2025 , Edited by admin on Tue Apr 01 20:38:39 GMT 2025
PRIMARY
SMS_ID
300000025293
Created by admin on Tue Apr 01 20:38:39 GMT 2025 , Edited by admin on Tue Apr 01 20:38:39 GMT 2025
PRIMARY
INN
10498
Created by admin on Tue Apr 01 20:38:39 GMT 2025 , Edited by admin on Tue Apr 01 20:38:39 GMT 2025
PRIMARY
NCI_THESAURUS
C171742
Created by admin on Tue Apr 01 20:38:39 GMT 2025 , Edited by admin on Tue Apr 01 20:38:39 GMT 2025
PRIMARY
ACTIVE MOIETY
AZINTUXIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966